Bottom line
FHCCX vs QAAGZX: the short answer
FHCCX (Fidelity Advisor Health Care Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds.
QAAGZX is cheaper at 0.86% vs 1.71% — a difference of $85 a year per $10,000 invested.
Over five years, QAAGZX returned +4.1% a year vs +2.8% for FHCCX (reporting dates differ).
Updated Nov 19, 2026
FHCCX vs QAAGZX side by side
| FHCCX | QAAGZX | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.71% | 0.86% |
| Annual cost per $10k | $171 | $86 |
| 10-yr cost on $10k (prospectus) | $1,821 | $1,061 |
| Max front load | — | None |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +12.5% | +18.1% |
| 5-yr return (annualized) | +2.8% | +4.1% |
| 10-yr return (annualized) | +7.6% | +9.0% |
| Best quarter | +21.3% | +23.4% |
| Worst quarter | −15.0% | −15.8% |
| Net assets (fund) | $3.1B | $751.7M |
| Number of holdings | 154 | 277 |
| Portfolio turnover | 74% | 65% |
| Returns as of | Sep 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of FHCCX's top 25 holdings also appear in QAAGZX's top 25.
| Holding | FHCCX | QAAGZX |
|---|---|---|
| ELI LILLY and CO | 7.66% | 14.06% |
| Danaher Corp | 6.75% | 1.44% |
| Thermo Fisher Scientific Inc | 6.31% | 2.53% |
| Unitedhealth Group Inc | 4.17% | 5.88% |
| JOHNSON and JOHNSON | 3.78% | 6.64% |
| Abbvie Inc | 3.62% | 5.12% |
| MERCK and CO INC | 2.09% | 4.00% |
| Natera Inc | 1.65% | 1.44% |
| Guardant Health Inc | 1.48% | 1.22% |
| Cvs Health Corp | 1.29% | 0.93% |
| Gilead Sciences Inc | 1.25% | 2.79% |
Source: SEC Form N-PORT
FHCCX top 10
- ELI LILLY and CO — 7.66%
- Danaher Corp — 6.75%
- Thermo Fisher Scientific Inc — 6.31%
- Unitedhealth Group Inc — 4.17%
- JOHNSON and JOHNSON — 3.78%
- Abbvie Inc — 3.62%
- Fidelity Revere Street Trust — 2.54%
- Argenx Se — 2.09%
- MERCK and CO INC — 2.09%
- West Pharmaceutical Svcs Inc — 2.06%
QAAGZX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FAQ
What is the difference between FHCCX and QAAGZX?
FHCCX (Fidelity Advisor Health Care Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds. QAAGZX is cheaper at 0.86% vs 1.71% — a difference of $85 a year per $10,000 invested.
Which is cheaper, FHCCX or QAAGZX?
QAAGZX has the lower expense ratio (0.86%).
Should I own both FHCCX and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.